← Leaderboards
Robert A. Rizza
Mayo Clinic Coll Of Medicine, Rochester
$75,563,326
Attributed
$77,111,509
Total exposure
48
Grants
33
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $27.8M · FY2005–13$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$168,468,111 · 51
By mechanism
UL1$131,311,520 · 29
KL2$17,177,372 · 2
M01$9,710,911 · 14
R01$5,708,488 · 1
TL1$2,513,615 · 1
R37$1,792,061 · 1
Top collaborators
- Rita Basu6 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Gregory A. Poland$55,246,205
- Kenton R. Kaufman$7,968,997
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectClinicResearch InfrastructureTranslational ResearchInsulinResearch PersonnelResourcesGlucose MetabolismNoninsulin Dependent Diabetes MellitusEvaluationVisionCommunitiesServicesSiteCaringInnovationMedicineHome EnvironmentMissionCollaborationsCollegeNext GenerationPatient Care
Grant awards (103)
Mechanisms of Insulin Resistance in Man$553,065
R01 · FY2013 · DK
Mechanisms of Insulin Resistance in Man$574,150
R01 · FY2012 · DK
Mayo Clinic Center for Translational Science Activities$10,689,073
UL1 · FY2011 · RR · contact PI
MAYO CLINIC CENTER FOR TRANSLATIONAL SCIENCE ACTIVITIES$6,137,024
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,280,156
UL1 · FY2011 · RR · contact PI
Mayo Clinic Center for Translational Science Activities$1,707,310
KL2 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,058,112
UL1 · FY2011 · RR · contact PI
Mechanisms of Insulin Resistance in Man$575,505
R01 · FY2011 · DK
Mayo Clinic Center for Translational Science Activities$515,682
TL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$106,891
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$106,890
UL1 · FY2011 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$10,919,773
UL1 · FY2010 · RR · contact PI
mayo clinic center for clinical and translational research$5,373,093
UL1 · FY2010 · RR · contact PI
ctsa infrastructure for clinical trials$3,385,130
UL1 · FY2010 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$2,691,959
KL2 · FY2010 · RR · contact PI
ctsa infrastructure for pediatric research$2,293,152
UL1 · FY2010 · RR · contact PI
Mechanisms of Insulin Resistance in Man$651,329
R01 · FY2010 · DK
Mayo Clinic Center for Clinical and Translational Research$571,270
TL1 · FY2010 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$349,997
UL1 · FY2010 · RR · contact PI
ctsa infrastructure for aids research$109,198
UL1 · FY2010 · RR · contact PI
CTSA Infrastructure for AIDS research$109,197
UL1 · FY2010 · RR · contact PI
Mechanisms of Insulin Resistance in Man$78,163
R01 · FY2010 · DK · contact PI
Mayo Clinic Center for Clinical and Translational Research$10,941,178
UL1 · FY2009 · RR · contact PI
MAYO CLINIC CENTER FOR CLINICAL AND TRANSLATIONAL RESEARCH$5,093,994
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,359,926
UL1 · FY2009 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$3,214,876
KL2 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,276,093
UL1 · FY2009 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$759,405
UL1 · FY2009 · RR · contact PI
Mechanisms of Insulin Resistance in Man$664,154
R01 · FY2009 · DK · contact PI
Mayo Clinic Center for Clinical and Translational Research$523,069
UL1 · FY2009 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$423,598
TL1 · FY2009 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$299,998
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$105,583
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$105,582
UL1 · FY2009 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$10,989,928
UL1 · FY2008 · RR · contact PI
MAYO CLINIC CENTER FOR CLINICAL AND TRANSLATIONAL RESEARCH$5,167,375
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,408,310
UL1 · FY2008 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$3,096,764
KL2 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,308,813
UL1 · FY2008 · RR · contact PI
Mechanisms of Insulin Resistance in Man$527,583
R01 · FY2008 · DK · contact PI
Mayo Clinic Center for Clinical and Translational Research$447,997
TL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$130,305
UL1 · FY2008 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$24,875
UL1 · FY2008 · RR · contact PI
INVESTIGATIONS ON GLUCONEOGENESIS$10,458
P41 · FY2008 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$11,624,779
UL1 · FY2007 · RR · contact PI
MAYO CLINIC CENTER FOR CLINICAL AND TRANSLATIONAL RESEARCH$5,463,646
UL1 · FY2007 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$3,603,681
UL1 · FY2007 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$2,790,883
KL2 · FY2007 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,441,204
UL1 · FY2007 · RR · contact PI
Mechanisms of Insulin Resistance in Man$522,996
R01 · FY2007 · DK · contact PI
Mayo Clinic Center for Clinical and Translational Research$331,628
TL1 · FY2007 · RR · contact PI
CTSA/NCRA COMMUNITY ENGAGEMENT SUPPLEMENT$217,399
UL1 · FY2007 · RR · contact PI
CTSA/NCRA Community Engagement Supplement$217,399
UL1 · FY2007 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$116,248
UL1 · FY2007 · RR · contact PI
INVESTIGATIONS ON GLUCONEOGENESIS$15,122
P41 · FY2007 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$9,107,522
UL1 · FY2006 · RR · contact PI
MAYO CLINIC CENTER FOR CLINICAL AND TRANSLATIONAL RESEARCH$4,189,460
UL1 · FY2006 · RR · contact PI
General Clinical Research Center$3,859,208
M01 · FY2006 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,823,331
UL1 · FY2006 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,003,654
UL1 · FY2006 · RR · contact PI
CTSA: K12 COMPONENT$1,837,790
KL2 · FY2006 · RR · contact PI
Mayo Clinic Center for Clinical and Translational Research$1,837,790
KL2 · FY2006 · RR · contact PI
Mechanisms of Insulin Resistance in Man$523,266
R01 · FY2006 · DK · contact PI
Mayo Clinic Center for Clinical and Translational Research$223,440
TL1 · FY2006 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$91,077
UL1 · FY2006 · RR · contact PI
General Clinical Research Center$5,710,816
M01 · FY2005 · RR
Mechanisms of Insulin Resistance in Man$522,027
R01 · FY2005 · DK
MECHANISMS OF POSTPRANDIAL HYPERGLYCEMIA IN HUMANS$83,641
M01 · FY2005 · RR
EFFECTS OF FREE FATTY ACIDS ON ENDOGENOUS GLUCOSE PRODUCTION$10,899
M01 · FY2005 · RR
Mechanisms of Insulin Resistance in Man$516,250
R01 · FY2004 · DK
Insulin Effect on Gluconeogenesis in Type 2 Diabetes$18,307
M01 · FY2004 · RR
Effect Of Type 2 Diabetes On Insulin Stimulated Splanchnic Glucose Uptake$15,295
M01 · FY2004 · RR
Comparison of the Dual and Triple Tracer Method$12,050
M01 · FY2004 · RR
Diabetes Prevention Trial - Type I Diabetes (DPT-1)$695
M01 · FY2004 · RR
MECHANISMS OF INSULIN RESISTANCE in Man$473,660
R37 · FY2003 · DK
MECHANISMS OF INSULIN RESISTANCE in Man$464,271
R37 · FY2002 · DK
EFFECTS OF GLP ON GLUCOSE EFFECTIVENESS$0
M01 · FY2002 · RR
EFFECTS OF GLP 1 ON INSULIN ACTION IN DIABETIC &NON DIABETIC SUBJECTS$0
M01 · FY2002 · RR
EFFECTS OF GLUCAGON ON CARBOHYDRATE METABOLISM IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2002 · RR
NON INSULIN DEPENDENT DIABETES MELLITUS ON MUSCLE &SPLANCHNIC GLUCOSE$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$0
M01 · FY2002 · RR
EFFECT OF ANDROGEN REPLACEMENT ON CARBOHYDRATE METABOLISM$0
P01 · FY2002 · AG
EFFECT OF ANDROGEN REPLACEMENT ON CARBOHYDRATE METABOLISM$0
P01 · FY2002 · AG
INCRETIN HORMONE GLP-1, MODE OF GLUCOSE DELIVERY &UPTAK$0
M01 · FY2002 · RR
GLUCAGON AND GLUCOSE RELEASE, GLYCOGENOLYSIS AND GLUCONEOGENESIS IN DIABETES$0
M01 · FY2002 · RR
MECHANISMS OF INSULIN RESISTANCE in Man$503,085
R37 · FY2001 · DK
EFFECT OF ANDROGEN REPLACEMENT ON CARBOHYDRATE METABOLISM$0
P01 · FY2001 · AG
INCRETIN HORMONE GLP-1, MODE OF GLUCOSE DELIVERY &UPTAK$0
M01 · FY2001 · RR
GLUCAGON AND GLUCOSE RELEASE, GLYCOGENOLYSIS AND GLUCONEOGENESIS IN DIABETES$0
M01 · FY2001 · RR
EFFECTS OF GLP ON GLUCOSE EFFECTIVENESS$0
M01 · FY2001 · RR
EFFECTS OF GLP 1 ON INSULIN ACTION IN DIABETIC &NON DIABETIC SUBJECTS$0
M01 · FY2001 · RR
EFFECTS OF GLUCAGON ON CARBOHYDRATE METABOLISM IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2001 · RR
NON INSULIN DEPENDENT DIABETES MELLITUS ON MUSCLE &SPLANCHNIC GLUCOSE$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$0
M01 · FY2001 · RR
MECHANISMS OF INSULIN RESISTANCE$351,045
R37 · FY2000 · DK
EFFECT OF ANDROGEN REPLACEMENT ON CARBOHYDRATE METABOLISM$228,564
P01 · FY2000 · AG
INCRETIN HORMONE GLP-1, MODE OF GLUCOSE DELIVERY &UPTAK$0
M01 · FY2000 · RR
GLUCAGON AND GLUCOSE RELEASE, GLYCOGENOLYSIS AND GLUCONEOGENESIS IN DIABETES$0
M01 · FY2000 · RR
EFFECTS OF GLP ON GLUCOSE EFFECTIVENESS$0
M01 · FY2000 · RR
EFFECTS OF GLP 1 ON INSULIN ACTION IN DIABETIC &NON DIABETIC SUBJECTS$0
M01 · FY2000 · RR
NON INSULIN DEPENDENT DIABETES MELLITUS ON MUSCLE &SPLANCHNIC GLUCOSE$0
M01 · FY2000 · RR
EFFECTS OF GLUCAGON ON CARBOHYDRATE METABOLISM IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES$0
M01 · FY2000 · RR